These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 16546306

  • 1. Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine.
    Elvin SJ, Eyles JE, Howard KA, Ravichandran E, Somavarappu S, Alpar HO, Williamson ED.
    Vaccine; 2006 May 15; 24(20):4433-9. PubMed ID: 16546306
    [Abstract] [Full Text] [Related]

  • 2. Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery.
    Tripathi V, Chitralekha KT, Bakshi AR, Tomar D, Deshmukh RA, Baig MA, Rao DN.
    Vaccine; 2006 Apr 12; 24(16):3279-89. PubMed ID: 16476510
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague.
    Williamson ED, Stagg AJ, Eley SM, Taylor R, Green M, Jones SM, Titball RW.
    Vaccine; 2007 Jan 22; 25(6):1142-8. PubMed ID: 17101198
    [Abstract] [Full Text] [Related]

  • 5. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE, Butcher WA, Titball RW, Hill J.
    Vaccine; 2007 Oct 16; 25(42):7301-6. PubMed ID: 17869388
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A, Cohen S, Levy Y, Halperin G, Lazar S, Velan B, Shafferman A, Flashner Y, Mamroud E.
    Vaccine; 2008 Mar 20; 26(13):1616-25. PubMed ID: 18304706
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates.
    Williamson ED, Flick-Smith HC, Waters E, Miller J, Hodgson I, Le Butt CS, Hill J.
    Microb Pathog; 2007 Jan 20; 42(1):11-21. PubMed ID: 17107769
    [Abstract] [Full Text] [Related]

  • 9. Immunisation against plague by transcutaneous and intradermal application of subunit antigens.
    Eyles JE, Elvin SJ, Westwood A, Lebutt CS, Alpar HO, Somavarapu S, Williamson ED.
    Vaccine; 2004 Oct 22; 22(31-32):4365-73. PubMed ID: 15474730
    [Abstract] [Full Text] [Related]

  • 10. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.
    Glynn A, Roy CJ, Powell BS, Adamovicz JJ, Freytag LC, Clements JD.
    Infect Immun; 2005 Aug 22; 73(8):5256-61. PubMed ID: 16041052
    [Abstract] [Full Text] [Related]

  • 11. Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen.
    Garmory HS, Freeman D, Brown KA, Titball RW.
    Vaccine; 2004 Feb 25; 22(8):947-57. PubMed ID: 15161071
    [Abstract] [Full Text] [Related]

  • 12. An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge.
    Palin A, Chattopadhyay A, Park S, Delmas G, Suresh R, Senina S, Perlin DS, Rose JK.
    Vaccine; 2007 Jan 08; 25(4):741-50. PubMed ID: 16959385
    [Abstract] [Full Text] [Related]

  • 13. A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.
    Sha J, Kirtley ML, Klages C, Erova TE, Telepnev M, Ponnusamy D, Fitts EC, Baze WB, Sivasubramani SK, Lawrence WS, Patrikeev I, Peel JE, Andersson JA, Kozlova EV, Tiner BL, Peterson JW, McWilliams D, Patel S, Rothe E, Motin VL, Chopra AK.
    Clin Vaccine Immunol; 2016 Jul 08; 23(7):586-600. PubMed ID: 27170642
    [Abstract] [Full Text] [Related]

  • 14. A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague.
    Williamson ED, Eley SM, Stagg AJ, Green M, Russell P, Titball RW.
    Vaccine; 1997 Jul 08; 15(10):1079-84. PubMed ID: 9269050
    [Abstract] [Full Text] [Related]

  • 15. Protective efficacy of a recombinant plague vaccine when co-administered with another sub-unit or live attenuated vaccine.
    Griffin K, Bedford R, Townson K, Phillpotts R, Funnell S, Morton M, Williamson D, Titball R.
    FEMS Immunol Med Microbiol; 2005 Mar 01; 43(3):425-30. PubMed ID: 15708318
    [Abstract] [Full Text] [Related]

  • 16. Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines.
    Eyles JE, Spiers ID, Williamson ED, Alpar HO.
    Vaccine; 1998 Dec 01; 16(20):2000-9. PubMed ID: 9796057
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 01; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 19. Microencapsulation of Streptococcus equi antigens in biodegradable microspheres and preliminary immunisation studies.
    Azevedo AF, Galhardas J, Cunha A, Cruz P, Gonçalves LM, Almeida AJ.
    Eur J Pharm Biopharm; 2006 Oct 01; 64(2):131-7. PubMed ID: 16846728
    [Abstract] [Full Text] [Related]

  • 20. Local and systemic immune response to a microencapsulated sub-unit vaccine for plague.
    Williamson ED, Sharp GJ, Eley SM, Vesey PM, Pepper TC, Titball RW, Alpar HO.
    Vaccine; 1996 Dec 01; 14(17-18):1613-9. PubMed ID: 9032889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.